369 followers
BRCA2, ATM, and CDK12 Defects Differentially Shape Prostate Tumor Driver Genomics and Clinical Aggression https://t.co/jP2oGeVZJn
2,504 followers
RT @ResearchWyatt: Our latest on clinical-genomic features of BRCA2, ATM, CDK12 defects in met PCa. All using ctDNA – implications for clin…
7,428 followers
BRCA2, ATM, and CDK12 Defects Differentially Shape Prostate Tumor Driver Genomics and Clinical Aggression https://t.co/0IoHZtSEfA
461 followers
RT @ResearchWyatt: Our latest on clinical-genomic features of BRCA2, ATM, CDK12 defects in met PCa. All using ctDNA – implications for clin…
2,928 followers
RT @ResearchWyatt: Look forward to building on these foundations to better predict PARPi response in a new @PCF_Science Challenge Award! We…
5,093 followers
RT @ResearchWyatt: Look forward to building on these foundations to better predict PARPi response in a new @PCF_Science Challenge Award! We…
502 followers
RT @ResearchWyatt: Our latest on clinical-genomic features of BRCA2, ATM, CDK12 defects in met PCa. All using ctDNA – implications for clin…
2,340 followers
RT @ResearchWyatt: Our latest on clinical-genomic features of BRCA2, ATM, CDK12 defects in met PCa. All using ctDNA – implications for clin…
718 followers
RT @ResearchWyatt: Our latest on clinical-genomic features of BRCA2, ATM, CDK12 defects in met PCa. All using ctDNA – implications for clin…
2,237 followers
Look forward to building on these foundations to better predict PARPi response in a new @PCF_Science Challenge Award! We'll be contributing to a multi-d clinical/genomics team led by visionary @vedangiri https://t.co/i2bgJzZN3g
16 followers
RT @ctSEQ_papers: PubMed_ BRCA2, ATM, and CDK12 defects differentially shape prostate tumor driver genomics and clinical aggression. https:…
167 followers
PubMed_ BRCA2, ATM, and CDK12 defects differentially shape prostate tumor driver genomics and clinical aggression. https://t.co/XJGOwtXH5x
458 followers
RT @AnthonyMJoshua: BRCA2, ATM, and CDK12 defects differentially shape prostate tumor driver genomics and clinical aggression | Clinical Ca…
1,136 followers
RT @ResearchWyatt: Our latest on clinical-genomic features of BRCA2, ATM, CDK12 defects in met PCa. All using ctDNA – implications for clin…
3,146 followers
For more on these findings and a link to the original publication, check out Dr Alexander Wyatt's thread below: https://t.co/9UaHbuWp8J
1,302 followers
264 followers
RT @ResearchWyatt: Our latest on clinical-genomic features of BRCA2, ATM, CDK12 defects in met PCa. All using ctDNA – implications for clin…
2,880 followers
RT @ResearchWyatt: Our latest on clinical-genomic features of BRCA2, ATM, CDK12 defects in met PCa. All using ctDNA – implications for clin…
3,152 followers
RT @ResearchWyatt: Our latest on clinical-genomic features of BRCA2, ATM, CDK12 defects in met PCa. All using ctDNA – implications for clin…
3,811 followers
RT @ResearchWyatt: Our latest on clinical-genomic features of BRCA2, ATM, CDK12 defects in met PCa. All using ctDNA – implications for clin…
151 followers
RT @ResearchWyatt: Our latest on clinical-genomic features of BRCA2, ATM, CDK12 defects in met PCa. All using ctDNA – implications for clin…
419 followers
RT @ResearchWyatt: Our latest on clinical-genomic features of BRCA2, ATM, CDK12 defects in met PCa. All using ctDNA – implications for clin…
7,428 followers
BRCA2, ATM, and CDK12 defects differentially shape prostate tumor driver genomics and clinical aggression https://t.co/jmyNc50LMw
1,207 followers
RT @ResearchWyatt: Our latest on clinical-genomic features of BRCA2, ATM, CDK12 defects in met PCa. All using ctDNA – implications for clin…
2,118 followers
RT @ResearchWyatt: Our latest on clinical-genomic features of BRCA2, ATM, CDK12 defects in met PCa. All using ctDNA – implications for clin…
634 followers
RT @ResearchWyatt: Our latest on clinical-genomic features of BRCA2, ATM, CDK12 defects in met PCa. All using ctDNA – implications for clin…
347 followers
RT @ResearchWyatt: Our latest on clinical-genomic features of BRCA2, ATM, CDK12 defects in met PCa. All using ctDNA – implications for clin…
6,874 followers
RT @ResearchWyatt: Our latest on clinical-genomic features of BRCA2, ATM, CDK12 defects in met PCa. All using ctDNA – implications for clin…
380 followers
RT @ResearchWyatt: Our latest on clinical-genomic features of BRCA2, ATM, CDK12 defects in met PCa. All using ctDNA – implications for clin…
233 followers
RT @ResearchWyatt: Our latest on clinical-genomic features of BRCA2, ATM, CDK12 defects in met PCa. All using ctDNA – implications for clin…
1,603 followers
RT @ResearchWyatt: Our latest on clinical-genomic features of BRCA2, ATM, CDK12 defects in met PCa. All using ctDNA – implications for clin…
208 followers
RT @ResearchWyatt: Our latest on clinical-genomic features of BRCA2, ATM, CDK12 defects in met PCa. All using ctDNA – implications for clin…
312 followers
Strong work from @ResearchWyatt and colleagues demonstrates how useful ctDNA is for studying DNA repair-deficient tumors. Great science and beautiful figures to explore a complex topic.
55 followers
RT @ResearchWyatt: Our latest on clinical-genomic features of BRCA2, ATM, CDK12 defects in met PCa. All using ctDNA – implications for clin…
2,102 followers
RT @ResearchWyatt: Our latest on clinical-genomic features of BRCA2, ATM, CDK12 defects in met PCa. All using ctDNA – implications for clin…
595 followers
Great work Alex and crew!
5,093 followers
RT @ResearchWyatt: Our latest on clinical-genomic features of BRCA2, ATM, CDK12 defects in met PCa. All using ctDNA – implications for clin…
2,237 followers
Our latest on clinical-genomic features of BRCA2, ATM, CDK12 defects in met PCa. All using ctDNA – implications for clinical roll-out! Mammoth lift from @UBC PhD students @ewarner_ubc @cherberts1 and team @VanProstateCtr and beyond. Online @CCR_AACR: https